| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hedgehog Proteins | 19 | 2024 | 771 | 5.080 |
Why?
|
| Medulloblastoma | 17 | 2024 | 682 | 3.670 |
Why?
|
| Axons | 15 | 2024 | 1675 | 2.840 |
Why?
|
| Nerve Growth Factors | 23 | 2014 | 564 | 2.830 |
Why?
|
| Axonal Transport | 10 | 2021 | 178 | 2.680 |
Why?
|
| Peripheral Nervous System Diseases | 6 | 2024 | 716 | 2.070 |
Why?
|
| Cerebellum | 20 | 2024 | 1521 | 2.050 |
Why?
|
| Cerebellar Neoplasms | 7 | 2024 | 590 | 2.050 |
Why?
|
| Receptors, Nerve Growth Factor | 17 | 2004 | 199 | 1.690 |
Why?
|
| Paclitaxel | 5 | 2024 | 1728 | 1.560 |
Why?
|
| Nerve Degeneration | 5 | 2024 | 748 | 1.520 |
Why?
|
| Ganglia, Spinal | 12 | 2025 | 529 | 1.280 |
Why?
|
| Neuroglia | 3 | 2025 | 960 | 1.170 |
Why?
|
| Endosomes | 5 | 2014 | 521 | 1.060 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2021 | 457 | 1.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 16 | 2009 | 606 | 1.020 |
Why?
|
| Neurons | 24 | 2025 | 9517 | 1.020 |
Why?
|
| Signal Transduction | 32 | 2023 | 23621 | 1.000 |
Why?
|
| Cell Survival | 12 | 2019 | 5750 | 0.990 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2024 | 617 | 0.980 |
Why?
|
| Receptor, trkA | 10 | 2014 | 159 | 0.930 |
Why?
|
| Neurogenesis | 3 | 2021 | 863 | 0.930 |
Why?
|
| Benzbromarone | 1 | 2024 | 7 | 0.920 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2024 | 89 | 0.810 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2021 | 17 | 0.790 |
Why?
|
| Armadillo Domain Proteins | 1 | 2021 | 25 | 0.780 |
Why?
|
| Neural Stem Cells | 3 | 2021 | 895 | 0.780 |
Why?
|
| Vincristine | 1 | 2024 | 1040 | 0.780 |
Why?
|
| Brain Neoplasms | 12 | 2024 | 9108 | 0.760 |
Why?
|
| Sensory Receptor Cells | 4 | 2021 | 509 | 0.750 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 12 | 2003 | 1621 | 0.730 |
Why?
|
| Schwann Cells | 1 | 2021 | 195 | 0.710 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2016 | 565 | 0.700 |
Why?
|
| Nerve Tissue Proteins | 11 | 2015 | 4401 | 0.690 |
Why?
|
| Animals | 99 | 2025 | 168965 | 0.680 |
Why?
|
| Cell Division | 11 | 2021 | 4473 | 0.670 |
Why?
|
| Rhombencephalon | 2 | 2020 | 81 | 0.650 |
Why?
|
| Neural Crest | 1 | 2021 | 277 | 0.640 |
Why?
|
| RNA | 2 | 2021 | 2715 | 0.620 |
Why?
|
| Proteoglycans | 2 | 2014 | 807 | 0.620 |
Why?
|
| Mice | 62 | 2024 | 81912 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1405 | 0.600 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2887 | 0.600 |
Why?
|
| Receptor, trkB | 8 | 2016 | 123 | 0.590 |
Why?
|
| Cell Proliferation | 7 | 2015 | 10455 | 0.560 |
Why?
|
| Societies, Scientific | 1 | 2018 | 223 | 0.560 |
Why?
|
| Hydroxamic Acids | 1 | 2019 | 483 | 0.540 |
Why?
|
| Retroelements | 1 | 2017 | 162 | 0.530 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1326 | 0.520 |
Why?
|
| Regulon | 1 | 2016 | 71 | 0.510 |
Why?
|
| Ornithine Decarboxylase | 1 | 2015 | 63 | 0.510 |
Why?
|
| Women, Working | 1 | 2016 | 86 | 0.490 |
Why?
|
| Dyneins | 3 | 2008 | 126 | 0.480 |
Why?
|
| Polyamines | 1 | 2015 | 132 | 0.480 |
Why?
|
| Lupus Erythematosus, Systemic | 14 | 2003 | 2160 | 0.470 |
Why?
|
| Cilia | 2 | 2023 | 498 | 0.470 |
Why?
|
| Wallerian Degeneration | 1 | 2014 | 68 | 0.460 |
Why?
|
| Neurosciences | 2 | 2020 | 384 | 0.460 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 777 | 0.460 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2015 | 506 | 0.460 |
Why?
|
| Organ Culture Techniques | 2 | 2015 | 789 | 0.450 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 262 | 0.450 |
Why?
|
| Cell Movement | 9 | 2015 | 5203 | 0.440 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 5794 | 0.430 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2040 | 0.430 |
Why?
|
| Proteins | 8 | 2019 | 6001 | 0.430 |
Why?
|
| Glypicans | 1 | 2013 | 33 | 0.430 |
Why?
|
| Olfactory Pathways | 1 | 2014 | 131 | 0.430 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 198 | 0.420 |
Why?
|
| Central Nervous System | 4 | 2023 | 1345 | 0.420 |
Why?
|
| Cell Differentiation | 8 | 2021 | 11657 | 0.420 |
Why?
|
| Astrocytoma | 4 | 2019 | 773 | 0.410 |
Why?
|
| Rats | 22 | 2021 | 23713 | 0.400 |
Why?
|
| Mutation | 15 | 2021 | 30211 | 0.390 |
Why?
|
| Mitochondria | 3 | 2021 | 3678 | 0.390 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 594 | 0.390 |
Why?
|
| ras Proteins | 3 | 2015 | 1054 | 0.390 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1337 | 0.380 |
Why?
|
| Receptors, Cell Surface | 4 | 2015 | 2815 | 0.380 |
Why?
|
| Cells, Cultured | 22 | 2017 | 18989 | 0.370 |
Why?
|
| bcl-X Protein | 1 | 2013 | 412 | 0.370 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2011 | 24 | 0.370 |
Why?
|
| Nerve Growth Factor | 3 | 2010 | 156 | 0.370 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2012 | 103 | 0.360 |
Why?
|
| Thermosensing | 1 | 2011 | 56 | 0.360 |
Why?
|
| Chemotactic Factors | 1 | 2011 | 197 | 0.360 |
Why?
|
| Nerve Regeneration | 1 | 2016 | 796 | 0.350 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2013 | 2883 | 0.340 |
Why?
|
| Calcium | 3 | 2021 | 5792 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2009 | 3610 | 0.340 |
Why?
|
| Career Choice | 1 | 2016 | 769 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 2843 | 0.330 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1178 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 5 | 2019 | 1492 | 0.320 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2009 | 69 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2019 | 1244 | 0.320 |
Why?
|
| Membrane Proteins | 5 | 2015 | 7868 | 0.310 |
Why?
|
| Chemotaxis | 3 | 2007 | 598 | 0.310 |
Why?
|
| Neural Pathways | 2 | 2014 | 3078 | 0.310 |
Why?
|
| Neuromuscular Junction | 1 | 2011 | 399 | 0.300 |
Why?
|
| Erectile Dysfunction | 1 | 2012 | 437 | 0.300 |
Why?
|
| Nervous System | 2 | 2020 | 543 | 0.300 |
Why?
|
| Cell Polarity | 2 | 2011 | 637 | 0.300 |
Why?
|
| Purkinje Cells | 4 | 2003 | 228 | 0.300 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2010 | 414 | 0.290 |
Why?
|
| Epidermis | 1 | 2011 | 539 | 0.290 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 515 | 0.290 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1244 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1119 | 0.290 |
Why?
|
| Behavior, Animal | 3 | 2011 | 1865 | 0.280 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2016 | 1150 | 0.280 |
Why?
|
| Glioma | 4 | 2015 | 3502 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 8108 | 0.280 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 521 | 0.280 |
Why?
|
| Apoptosis | 11 | 2014 | 9513 | 0.280 |
Why?
|
| Receptor, trkC | 8 | 2009 | 63 | 0.280 |
Why?
|
| Nociceptors | 1 | 2011 | 460 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2009 | 4522 | 0.270 |
Why?
|
| Smell | 1 | 2009 | 259 | 0.270 |
Why?
|
| RNA, Messenger | 8 | 2021 | 12793 | 0.260 |
Why?
|
| Mice, Knockout | 11 | 2023 | 14476 | 0.250 |
Why?
|
| Trans-Activators | 3 | 2005 | 2856 | 0.250 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2429 | 0.250 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4280 | 0.250 |
Why?
|
| Satellite Cells, Perineuronal | 1 | 2025 | 4 | 0.250 |
Why?
|
| Receptors, CXCR4 | 4 | 2006 | 729 | 0.240 |
Why?
|
| Cytoplasmic Granules | 3 | 2021 | 574 | 0.240 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2009 | 610 | 0.240 |
Why?
|
| Amino Acid Sequence | 8 | 2024 | 13411 | 0.240 |
Why?
|
| Anilides | 2 | 2019 | 413 | 0.230 |
Why?
|
| Phosphorylation | 10 | 2021 | 8310 | 0.230 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9551 | 0.220 |
Why?
|
| Humans | 76 | 2025 | 767040 | 0.220 |
Why?
|
| Mitosis | 1 | 2009 | 1176 | 0.220 |
Why?
|
| Glioblastoma | 4 | 2015 | 3461 | 0.220 |
Why?
|
| Multipotent Stem Cells | 1 | 2005 | 201 | 0.220 |
Why?
|
| Mice, Mutant Strains | 4 | 2021 | 1751 | 0.220 |
Why?
|
| Body Patterning | 2 | 2009 | 634 | 0.210 |
Why?
|
| Presynaptic Terminals | 2 | 2002 | 299 | 0.210 |
Why?
|
| Transcription Factors | 3 | 2016 | 12158 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 12 | 2011 | 6226 | 0.200 |
Why?
|
| Ferrets | 1 | 2023 | 181 | 0.200 |
Why?
|
| Neurotrophin 3 | 7 | 2003 | 61 | 0.200 |
Why?
|
| Neurites | 4 | 2008 | 389 | 0.200 |
Why?
|
| PC12 Cells | 6 | 2008 | 317 | 0.190 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2002 | 111 | 0.190 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 3702 | 0.190 |
Why?
|
| Dendrites | 3 | 2016 | 471 | 0.190 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2001 | 15 | 0.190 |
Why?
|
| Immunohistochemistry | 11 | 2015 | 11063 | 0.190 |
Why?
|
| Biphenyl Compounds | 2 | 2019 | 1026 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 426 | 0.190 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1646 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2021 | 1074 | 0.180 |
Why?
|
| Pentoxifylline | 1 | 2001 | 53 | 0.180 |
Why?
|
| Nervous System Malformations | 1 | 2003 | 243 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2019 | 1608 | 0.180 |
Why?
|
| NAD | 1 | 2024 | 618 | 0.170 |
Why?
|
| Germinoma | 1 | 2001 | 132 | 0.170 |
Why?
|
| Pyridines | 3 | 2019 | 2890 | 0.170 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2014 | 247 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2012 | 3044 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4925 | 0.160 |
Why?
|
| Rett Syndrome | 1 | 2001 | 164 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2979 | 0.160 |
Why?
|
| Imidazolidines | 1 | 1999 | 38 | 0.160 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 498 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2017 | 3608 | 0.160 |
Why?
|
| Animals, Newborn | 5 | 2009 | 2677 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 3 | 2019 | 940 | 0.150 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 464 | 0.150 |
Why?
|
| Protein Binding | 5 | 2024 | 9327 | 0.150 |
Why?
|
| Autoantibodies | 4 | 1995 | 2114 | 0.150 |
Why?
|
| Sensory Thresholds | 2 | 2011 | 377 | 0.150 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 2058 | 0.150 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 928 | 0.150 |
Why?
|
| Synapses | 2 | 2011 | 1759 | 0.150 |
Why?
|
| Calcium Channels | 1 | 2021 | 622 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2024 | 956 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 663 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2005 | 2927 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 385 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2875 | 0.140 |
Why?
|
| Peer Review, Research | 1 | 2020 | 343 | 0.140 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 17097 | 0.140 |
Why?
|
| Cerebellar Cortex | 1 | 1998 | 108 | 0.140 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 4 | 1999 | 36 | 0.140 |
Why?
|
| Bromodeoxyuridine | 2 | 2009 | 310 | 0.140 |
Why?
|
| raf Kinases | 1 | 2017 | 117 | 0.140 |
Why?
|
| Cell Communication | 2 | 2002 | 1660 | 0.140 |
Why?
|
| COS Cells | 2 | 2013 | 1135 | 0.140 |
Why?
|
| Cytokines | 5 | 2000 | 7446 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 1892 | 0.130 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2020 | 4426 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 1998 | 151 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 988 | 0.130 |
Why?
|
| Type C Phospholipases | 3 | 2003 | 287 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 11923 | 0.130 |
Why?
|
| Lamin Type B | 1 | 2016 | 28 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 874 | 0.130 |
Why?
|
| Integrin alpha3beta1 | 1 | 2015 | 53 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4572 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2009 | 66 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2001 | 724 | 0.130 |
Why?
|
| Th2 Cells | 3 | 2000 | 1077 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 4 | 2003 | 340 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2015 | 5022 | 0.120 |
Why?
|
| Chlamydomonas | 2 | 1985 | 10 | 0.120 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2015 | 97 | 0.120 |
Why?
|
| Chemokines, CXC | 3 | 2003 | 420 | 0.120 |
Why?
|
| Peptides | 3 | 2021 | 4348 | 0.120 |
Why?
|
| Cell Count | 3 | 2011 | 1825 | 0.120 |
Why?
|
| Th1 Cells | 2 | 1997 | 1040 | 0.120 |
Why?
|
| Neurobiology | 1 | 2016 | 135 | 0.120 |
Why?
|
| Female | 37 | 2024 | 396660 | 0.120 |
Why?
|
| DNA, Single-Stranded | 2 | 1994 | 351 | 0.120 |
Why?
|
| Olfactory Marker Protein | 1 | 2014 | 12 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1996 | 301 | 0.120 |
Why?
|
| North America | 1 | 2018 | 1287 | 0.120 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 3726 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2001 | 806 | 0.120 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 296 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2013 | 203 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22361 | 0.110 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2014 | 122 | 0.110 |
Why?
|
| Stem Cells | 4 | 2013 | 3535 | 0.110 |
Why?
|
| Patient Admission | 1 | 2001 | 1364 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 3 | 2009 | 2063 | 0.110 |
Why?
|
| Caspase 6 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 1446 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2015 | 3618 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 1512 | 0.110 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 1676 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 2628 | 0.100 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2014 | 102 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2001 | 1390 | 0.100 |
Why?
|
| Methotrexate | 3 | 1997 | 1718 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5332 | 0.100 |
Why?
|
| Transfection | 4 | 2009 | 5753 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2001 | 4349 | 0.100 |
Why?
|
| Genes, fos | 1 | 1992 | 176 | 0.100 |
Why?
|
| Microspheres | 1 | 2015 | 774 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 635 | 0.100 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2002 | 110 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.100 |
Why?
|
| Mice, Inbred C3H | 4 | 2000 | 915 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 961 | 0.100 |
Why?
|
| Aging | 4 | 2010 | 8729 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2013 | 11872 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1697 | 0.100 |
Why?
|
| International Cooperation | 1 | 2018 | 1434 | 0.100 |
Why?
|
| Morpholines | 2 | 2013 | 584 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1604 | 0.090 |
Why?
|
| Europe | 1 | 2018 | 3432 | 0.090 |
Why?
|
| Base Sequence | 2 | 2021 | 12414 | 0.090 |
Why?
|
| Male | 26 | 2024 | 364203 | 0.090 |
Why?
|
| Complementarity Determining Regions | 2 | 2003 | 154 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2001 | 2594 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2011 | 18330 | 0.090 |
Why?
|
| Cell Enlargement | 1 | 2010 | 58 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 474 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 8628 | 0.090 |
Why?
|
| Synaptic Transmission | 3 | 2002 | 1175 | 0.080 |
Why?
|
| Endocytosis | 2 | 2007 | 951 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 478 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3797 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 1991 | 471 | 0.080 |
Why?
|
| Gene Expression | 4 | 2010 | 7587 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2013 | 578 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 1991 | 447 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 492 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3828 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1019 | 0.080 |
Why?
|
| Inositol | 1 | 2010 | 216 | 0.080 |
Why?
|
| Organ Size | 1 | 2014 | 2264 | 0.080 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 88 | 0.080 |
Why?
|
| Phosphopeptides | 2 | 2002 | 240 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 9532 | 0.080 |
Why?
|
| Heparin | 2 | 2009 | 1636 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2002 | 1081 | 0.080 |
Why?
|
| Astrocytes | 1 | 2016 | 1352 | 0.080 |
Why?
|
| Binding Sites | 4 | 2002 | 6014 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14766 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2001 | 501 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1716 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3427 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2003 | 6611 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1928 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1889 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2011 | 706 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2014 | 1147 | 0.070 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2007 | 163 | 0.070 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2007 | 187 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1331 | 0.070 |
Why?
|
| Child | 11 | 2024 | 80771 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Benzylamines | 2 | 2006 | 251 | 0.070 |
Why?
|
| Heterocyclic Compounds | 2 | 2006 | 245 | 0.070 |
Why?
|
| Pregnancy | 4 | 2023 | 30238 | 0.070 |
Why?
|
| Receptor, Nerve Growth Factor | 2 | 2003 | 48 | 0.070 |
Why?
|
| Chemokine CXCL12 | 3 | 2003 | 457 | 0.070 |
Why?
|
| Veratrum Alkaloids | 1 | 2005 | 23 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2007 | 234 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2007 | 246 | 0.060 |
Why?
|
| Patient Preference | 1 | 2013 | 947 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2902 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2011 | 672 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 17608 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2001 | 1688 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2015 | 1647 | 0.060 |
Why?
|
| RNA Interference | 2 | 2015 | 2829 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 4 | 2019 | 6106 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
| Phosphotransferases | 1 | 2005 | 302 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 3738 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 9612 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 2001 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 2 | 2015 | 467 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2000 | 2448 | 0.060 |
Why?
|
| Lentivirus | 1 | 2007 | 518 | 0.060 |
Why?
|
| Exercise | 1 | 2001 | 5954 | 0.060 |
Why?
|
| Flagella | 1 | 1984 | 97 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7611 | 0.060 |
Why?
|
| Neuropeptides | 2 | 2007 | 950 | 0.060 |
Why?
|
| HIV-1 | 1 | 2001 | 6951 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2008 | 1504 | 0.050 |
Why?
|
| Physicians | 1 | 2001 | 4593 | 0.050 |
Why?
|
| Phenotype | 5 | 2011 | 16718 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 1359 | 0.050 |
Why?
|
| Phospholipase C gamma | 2 | 2001 | 130 | 0.050 |
Why?
|
| Neoplasms | 2 | 2020 | 22350 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3944 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 72 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 316 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2002 | 178 | 0.050 |
Why?
|
| Myelin Proteins | 1 | 2002 | 212 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 713 | 0.050 |
Why?
|
| Immunization | 2 | 1997 | 1218 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1089 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2002 | 241 | 0.050 |
Why?
|
| Polyomavirus | 1 | 2002 | 235 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 1999 | 6360 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2024 | 804 | 0.050 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2002 | 137 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2001 | 245 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2002 | 228 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2009 | 1266 | 0.050 |
Why?
|
| Lupus Nephritis | 2 | 1995 | 324 | 0.050 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2002 | 168 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 8048 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5693 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 2 | 1992 | 512 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2002 | 187 | 0.040 |
Why?
|
| Protein Transport | 2 | 2008 | 1944 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2002 | 369 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13650 | 0.040 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 192 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 21178 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 2000 | 347 | 0.040 |
Why?
|
| Ontario | 1 | 2001 | 403 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 2012 | 0.040 |
Why?
|
| Interleukin-1 | 3 | 2000 | 1252 | 0.040 |
Why?
|
| Dynamins | 1 | 2000 | 141 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2013 | 11217 | 0.040 |
Why?
|
| Anesthesia | 1 | 2011 | 1595 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 1999 | 11097 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2005 | 2200 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2001 | 184 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 924 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 437 | 0.040 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2005 | 951 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2726 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2009 | 2079 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 1 | 2000 | 107 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1062 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 1144 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2020 | 202 | 0.040 |
Why?
|
| Adolescent | 4 | 2024 | 89046 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1999 | 95 | 0.040 |
Why?
|
| Models, Neurological | 2 | 1998 | 1747 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2002 | 627 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 3760 | 0.040 |
Why?
|
| Histones | 1 | 2009 | 2597 | 0.040 |
Why?
|
| Seizures | 1 | 1991 | 2996 | 0.040 |
Why?
|
| Kinetics | 3 | 2008 | 6287 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 5 | 2001 | 9245 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 447 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1998 | 107 | 0.040 |
Why?
|
| Rodentia | 1 | 2019 | 262 | 0.040 |
Why?
|
| Quality of Life | 3 | 2013 | 13485 | 0.040 |
Why?
|
| Career Mobility | 1 | 2020 | 262 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 2745 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1997 | 2428 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 7121 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 59980 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1526 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2001 | 469 | 0.040 |
Why?
|
| Indoles | 1 | 2005 | 1836 | 0.040 |
Why?
|
| Lymphocyte Activation | 4 | 2003 | 5499 | 0.040 |
Why?
|
| Leuprolide | 1 | 1999 | 313 | 0.030 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1997 | 44 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2003 | 2457 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2000 | 525 | 0.030 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1996 | 46 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1997 | 434 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1741 | 0.030 |
Why?
|
| Vanadates | 1 | 1996 | 82 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2000 | 572 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1736 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1997 | 360 | 0.030 |
Why?
|
| Anti-HIV Agents | 2 | 2003 | 4567 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1996 | 213 | 0.030 |
Why?
|
| Adult | 8 | 2024 | 223317 | 0.030 |
Why?
|
| Glycosylation | 1 | 1999 | 1099 | 0.030 |
Why?
|
| Tyrosine | 1 | 2000 | 1425 | 0.030 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1996 | 77 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2003 | 1610 | 0.030 |
Why?
|
| Sensation Disorders | 1 | 1997 | 160 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 766 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 458 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 102 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2001 | 1788 | 0.030 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 120 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2019 | 539 | 0.030 |
Why?
|
| Reference Values | 3 | 2000 | 4918 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2201 | 0.030 |
Why?
|
| Rabbits | 1 | 2001 | 4751 | 0.030 |
Why?
|
| Acetylation | 1 | 1997 | 1055 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1999 | 582 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 327 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2000 | 2605 | 0.030 |
Why?
|
| HIV Infections | 1 | 2001 | 17542 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4032 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2668 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1999 | 3073 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1994 | 861 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 759 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 705 | 0.030 |
Why?
|
| Imidazoles | 1 | 1999 | 1169 | 0.030 |
Why?
|
| Thymidine | 1 | 1992 | 297 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 1902 | 0.030 |
Why?
|
| DNA | 3 | 1992 | 7210 | 0.030 |
Why?
|
| Gait | 1 | 1998 | 823 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2015 | 10092 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 518 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2001 | 3552 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1994 | 748 | 0.020 |
Why?
|
| Leukopenia | 1 | 1992 | 212 | 0.020 |
Why?
|
| Oils, Volatile | 1 | 1991 | 14 | 0.020 |
Why?
|
| Prognosis | 4 | 2015 | 29963 | 0.020 |
Why?
|
| Microtubules | 2 | 2008 | 1062 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 1705 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 2412 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 1991 | 167 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1029 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1370 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5141 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 432 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 1999 | 1412 | 0.020 |
Why?
|
| Proteomics | 1 | 2024 | 3913 | 0.020 |
Why?
|
| Laryngeal Masks | 1 | 2011 | 118 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1992 | 2472 | 0.020 |
Why?
|
| Occupational Therapy | 1 | 1991 | 140 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1997 | 1081 | 0.020 |
Why?
|
| Antibodies | 1 | 1997 | 2419 | 0.020 |
Why?
|
| Proteinuria | 1 | 1992 | 613 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 951 | 0.020 |
Why?
|
| Laryngoscopes | 1 | 2011 | 147 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1997 | 1939 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2509 | 0.020 |
Why?
|
| Boston | 1 | 2001 | 9360 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 1991 | 10254 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2721 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3611 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2391 | 0.020 |
Why?
|
| Mice, SCID | 1 | 1992 | 2626 | 0.020 |
Why?
|
| Carmustine | 1 | 2006 | 137 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 3804 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2001 | 4054 | 0.020 |
Why?
|
| Social Environment | 1 | 1991 | 1012 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4968 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2001 | 4859 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 1997 | 4560 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2015 | 42606 | 0.020 |
Why?
|
| Fetus | 1 | 1992 | 1878 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 4787 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2001 | 4745 | 0.010 |
Why?
|
| Infant | 4 | 2015 | 36485 | 0.010 |
Why?
|
| Interleukin-4 | 2 | 2000 | 1156 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1997 | 4210 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 6215 | 0.010 |
Why?
|
| Zebrafish | 1 | 2015 | 3036 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18401 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 1991 | 986 | 0.010 |
Why?
|
| Chick Embryo | 2 | 2002 | 973 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 1966 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1729 | 0.010 |
Why?
|
| Interleukin-10 | 2 | 2000 | 1182 | 0.010 |
Why?
|
| Collagen | 1 | 1991 | 2636 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1759 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1502 | 0.010 |
Why?
|
| JC Virus | 1 | 2002 | 87 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1999 | 3587 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1984 | 2168 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 816 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 2002 | 291 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40154 | 0.010 |
Why?
|
| Antigens, Neoplasm | 2 | 2002 | 1997 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1991 | 2429 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 256 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1992 | 2099 | 0.010 |
Why?
|
| BK Virus | 1 | 2002 | 120 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 2001 | 165 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 9410 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2002 | 472 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2001 | 5947 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1984 | 2551 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 5537 | 0.010 |
Why?
|
| Genes | 1 | 1984 | 1824 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2000 | 224 | 0.010 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2000 | 200 | 0.010 |
Why?
|
| Epirubicin | 1 | 1999 | 82 | 0.010 |
Why?
|
| Light | 1 | 1985 | 1358 | 0.010 |
Why?
|
| Amino Acids | 1 | 1985 | 1712 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2001 | 339 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 305 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 2415 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3621 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1980 | 563 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2001 | 41718 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1986 | 1023 | 0.010 |
Why?
|
| Middle Aged | 5 | 2013 | 223233 | 0.010 |
Why?
|
| Neoplasms, Experimental | 2 | 2000 | 1228 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 39317 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 2093 | 0.010 |
Why?
|
| Chromones | 1 | 1997 | 148 | 0.010 |
Why?
|
| Fibronectins | 1 | 1980 | 722 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 2794 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2001 | 736 | 0.010 |
Why?
|
| Methimazole | 1 | 1996 | 41 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36582 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2003 | 1894 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1991 | 9362 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1986 | 2257 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1991 | 6282 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1991 | 3778 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1996 | 151 | 0.010 |
Why?
|
| Androstadienes | 1 | 1997 | 348 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 1995 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26396 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2003 | 2575 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 2827 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 4143 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2003 | 2322 | 0.010 |
Why?
|
| Cisplatin | 1 | 1999 | 1656 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 1765 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2000 | 1248 | 0.010 |
Why?
|
| Cadaver | 1 | 1997 | 1362 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 81659 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 26325 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 1886 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1996 | 1442 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1991 | 211 | 0.010 |
Why?
|
| Tamoxifen | 1 | 1996 | 966 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 1889 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1999 | 1536 | 0.010 |
Why?
|
| Spleen | 1 | 1977 | 2292 | 0.010 |
Why?
|
| Sick Role | 1 | 1991 | 229 | 0.010 |
Why?
|
| Personality Development | 1 | 1991 | 241 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1991 | 355 | 0.010 |
Why?
|
| Ligands | 1 | 1997 | 3273 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 1991 | 180 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2800 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 1999 | 2463 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2000 | 5891 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 1991 | 276 | 0.010 |
Why?
|
| Brain | 2 | 1997 | 27163 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1998 | 2056 | 0.000 |
Why?
|
| Israel | 1 | 1991 | 726 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1997 | 3154 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1997 | 1811 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 3440 | 0.000 |
Why?
|
| Cell Line | 1 | 2002 | 15567 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 59548 | 0.000 |
Why?
|
| Candida albicans | 1 | 1991 | 376 | 0.000 |
Why?
|
| Treatment Outcome | 2 | 2006 | 65295 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1991 | 1392 | 0.000 |
Why?
|
| Phentolamine | 1 | 1986 | 102 | 0.000 |
Why?
|
| Genotype | 1 | 2000 | 13035 | 0.000 |
Why?
|
| Antirheumatic Agents | 1 | 1996 | 1379 | 0.000 |
Why?
|
| Professional-Patient Relations | 1 | 1991 | 724 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1991 | 1334 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1991 | 976 | 0.000 |
Why?
|
| Aged | 2 | 2013 | 171319 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1977 | 3468 | 0.000 |
Why?
|
| Catecholamines | 1 | 1986 | 388 | 0.000 |
Why?
|
| Endocardium | 1 | 1986 | 249 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 1969 | 0.000 |
Why?
|
| Home Care Services | 1 | 1991 | 659 | 0.000 |
Why?
|
| Propranolol | 1 | 1986 | 493 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1991 | 1072 | 0.000 |
Why?
|
| Insulin | 1 | 1997 | 6602 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2000 | 22254 | 0.000 |
Why?
|
| Epitopes | 1 | 1988 | 2526 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 1002 | 0.000 |
Why?
|
| Fluoresceins | 1 | 1980 | 235 | 0.000 |
Why?
|
| Bacteria | 1 | 1991 | 2212 | 0.000 |
Why?
|
| Gelatin | 1 | 1980 | 227 | 0.000 |
Why?
|
| Mercaptoethanol | 1 | 1978 | 61 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 18063 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1978 | 339 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1978 | 294 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1978 | 939 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1978 | 610 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1977 | 496 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1986 | 3464 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1986 | 3837 | 0.000 |
Why?
|
| Myocardium | 1 | 1986 | 4765 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1991 | 7469 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1986 | 6409 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1986 | 5914 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1977 | 3642 | 0.000 |
Why?
|
| Glucose | 1 | 1978 | 4341 | 0.000 |
Why?
|
| Melanoma | 1 | 1977 | 5702 | 0.000 |
Why?
|